| Drug Patent Number | Company | Drug Patent Title | Drug Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US5607979 | US ARMY MED RES | Topical skin protectants |
May, 2015
(8 years ago) | |
Skin Exposure Reduction Paste Against Chemical Warfare Agents is owned by Us Army Med Res.
Skin Exposure Reduction Paste Against Chemical Warfare Agents contains Perfluoropolymethylisopropyl Ether; Polytetrafluoroethylene.
Skin Exposure Reduction Paste Against Chemical Warfare Agents has a total of 1 drug patent out of which 1 drug patent has expired.
Expired drug patents of Skin Exposure Reduction Paste Against Chemical Warfare Agents are:
- US5607979
Skin Exposure Reduction Paste Against Chemical Warfare Agents was authorised for market use on 17 February, 2000.
Skin Exposure Reduction Paste Against Chemical Warfare Agents is available in paste;topical dosage forms.
The generics of Skin Exposure Reduction Paste Against Chemical Warfare Agents are possible to be released after 30 May, 2015.
Drugs and Companies using PERFLUOROPOLYMETHYLISOPROPYL ETHER; POLYTETRAFLUOROETHYLENE ingredient
Market Authorisation Date: 17 February, 2000
Treatment: NA
Dosage: PASTE;TOPICAL
SKIN EXPOSURE REDUCTION PASTE AGAINST CHEMICAL WARFARE AGENTS family patents
